Sex and Gender-Related Differences in COVID-19 Diagnoses and SARS-CoV-2 Testing Practices During the First Wave of the Pandemic: The Dutch Lifelines COVID-19 Cohort Study

Abstract

Background: Although sex differences are described in Coronavirus Disease 2019 (COVID-19) diagnoses and testing, many studies neglect possible gender-related influences. Additionally, research is often performed in clinical populations, while most COVID-19 patients are not hospitalized. Therefore, we investigated associations between sex and gender-related variables, and COVID-19 diagnoses and testing practices in a large general population cohort during the first wave of the pandemic when testing capacity was limited. Methods: We used data from the Lifelines COVID-19 Cohort ( N = 74,722; 60.8% female). We applied bivariate and multiple logistic regression analyses. The outcomes were a COVID-19 diagnosis (confirmed by SARS-CoV-2 PCR testing or physician's clinical diagnosis) and PCR testing. Independent variables included among others participants' sex, age, somatic comorbidities, occupation, and smoking status. Sex-by-comorbidity and sex-by-occupation interaction terms were included to investigate sex differences in associations between the presence of comorbidities or an occupation with COVID-19 diagnoses or testing practices. Results: In bivariate analyses female sex was significantly associated with COVID-19 diagnoses and testing, but significance did not persist in multiple logistic regression analyses. However, a gender-related variable, being a health care worker, was significantly associated with COVID-19 diagnoses (OR = 1.68; 95%CI = 1.30–2.17) and testing (OR = 12.5; 95%CI = 8.55–18.3). Female health care workers were less often diagnosed and tested than male health care workers (OR interaction = 0.54; 95%CI = 0.32–0.92, OR interaction = 0.53; 95%CI = 0.29–0.97, respectively). Conclusions: We found no sex differences in COVID-19 diagnoses and testing in the general population. Among health care workers, a male preponderance in COVID-19 diagnoses and testing was observed. This could be explained by more pronounced COVID-19 symptoms in males or by gender inequities.

Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study

“…Interestingly, reinfection seemed to be more frequent among females, which might be a consequence of the lower attitude to routine diagnostic testing of the males ( 14 ), as well as the higher work-related exposure to the contagion of the females ( 15 ).…”

Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study

“…5 Furthermore, most studies have relied on follow-up of hospitalised patients with COVID-19. 4 The vast majority of people with COVID-19, however, have mild disease and are not hospitalised, 6 and hospitalisation itself is associated with somatic symptoms. 7 Another complicating factor is that there is no consensus on the nature of the symptoms that can be attributed to COVID-19.…”

Characterization of persons with reported SARS-CoV-2 infection in the Oklahoma City tri-county area: Evidence from the first 12 months of transmission

“…This, in turn, has impacted the number of persons testing positive and ultimately the results that we highlight in relation to trends over time. Finally, SARS-CoV-2 testing has been shown to be biased, with certain population groups including Black and African Americans being more likely to test for infection than others 2 , 11 , 27 , 28 , 29 . Demographic variations in test-seeking behavior could have impacted our results by introducing a proportionally higher case rate and an artificially inflated odds of hospitalization or death among this population group.…”